Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI024720-06S1
Application #
3137916
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1986-09-01
Project End
1993-08-31
Budget Start
1992-07-01
Budget End
1992-08-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Type
Schools of Medicine
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Crowell, R E; Hallin, G; Heaphy, E et al. (1995) Hyperoxic suppression of Fc-gamma receptor-mediated phagocytosis by isolated murine pulmonary macrophages. Am J Respir Cell Mol Biol 12:190-5
Reilly, B D; Makrides, S C; Ford, P J et al. (1994) Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J Biol Chem 269:7696-701
Wang, R H; Phillips Jr, G; Medof, M E et al. (1993) Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 92:1326-35
Hicks, P S; Saunero-Nava, L; Du Clos, T W et al. (1992) Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol 149:3689-94
Crowell, R E; Du Clos, T W; Montoya, G et al. (1991) C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI. J Immunol 147:3445-51
Mold, C; Walter, E I; Medof, M E (1990) The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor. J Immunol 145:3836-41
Mold, C (1989) Effect of membrane phospholipids on activation of the alternative complement pathway. J Immunol 143:1663-8
Mold, C; Nemerow, G R; Bradt, B M et al. (1988) CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J Immunol 140:1923-9
Mold, C; Bradt, B M; Nemerow, G R et al. (1988) Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350. J Immunol 140:3867-74
Mold, C; Bradt, B M; Nemerow, G R et al. (1988) Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 168:949-69

Showing the most recent 10 out of 12 publications